As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Thermo Fisher Scientific: Caas Capital Management LP, Simplex Trading LLC, Readystate Asset Management LP, Parallax Volatility Advisers L.P., BlueCrest Capital Management Ltd, Caas Capital Management LP, Citadel Advisors LLC, Royal Bank of Canada, Point72 Asset Management L.P., Balyasny Asset Management L.P., Verition Fund Management LLC, Capital Fund Management S.A., Eisler Capital UK Ltd., Capstone Investment Advisors LLC, Allianz Asset Management GmbH, Hsbc Holdings PLC, Mendel Money Management, IMC Chicago LLC, Wells Fargo & Company MN, UBS Group AG, Baader Bank Aktiengesellschaft, BNP Paribas Financial Markets, Gladius Capital Management LP, CenterStar Asset Management LLC, Concourse Financial Group Securities Inc., XR Securities LLC, Wolverine Asset Management LLC, and SpiderRock Advisors LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.